Our featured guest today is Ruth Venning, Executive Director at Horizon Therapeutics, and Chair of NIRI’s Board of Directors.  Hear about Ruth’s interesting start in investor relations, which was inspired by a college course in IR.  Ruth anticipates more IR challenges in 2021, however, she believes that crises bring opportunities. Ruth discusses how NIRI met the challenge of transforming an in-person annual conference to a well-received virtual program.

Our featured guest today is Ruth Venning, Executive Director at Horizon Therapeutics, and Chair of NIRI’s Board of Directors. Hear about Ruth’s interesting start in investor relations, which was inspired by a college course in IR. Ruth anticipates more IR challenges in 2021, however, she believes that crises bring opportunities. Ruth discusses how NIRI met the challenge of transforming an in-person annual conference to a well-received virtual program.

Our featured guest today is Ruth Venning, Executive Director at Horizon Therapeutics, and Chair of NIRI’s Board of Directors.&nbsp; Hear about Ruth’s interesting start in investor relations, which was inspired by a college course in IR.&nbsp; Ruth anticipates more IR challenges in 2021, however, she believes that crises bring opportunities.&nbsp;Ruth discusses how NIRI met the challenge of transforming an in-person annual conference to a well-received virtual program.

Episode 7: Ruth Venning, IRC

Presented by the National Investor Relations Institute (NIRI), the largest association for investor relations professionals in the world.

Share Episode 7: Ruth Venning, IRC

Sign up to save your podcasts

Episode 7: Ruth Venning, IRC

Episode 7: Ruth Venning, IRC